Dr Angeles Escarti-Nebot is a Principal Consultant and Head of the Nonclinical team at Scendea. Angeles has previously held positions in Parexel, PharmLex, nonclinical CROs and Academia.
Angeles has a strong scientific background with more than seven years’ experience on biotechnology and more than 15 years’ experience in a regulatory environment.
Her main areas of expertise include Global Regulatory Strategy, Non-clinical and Quality development programs for biological and biotechnological products, cell and gene-based products as well as tissue engineered products for the US, EU and UK markets.
Angeles holds a PhD in Molecular and Cellular Biology, BA in Pharmacy, MS in clinical Genetics and MS in Neuropharmacology.